Publication Type:

Journal Article

Source:

Indian Journal of Clinical Biochemistry, Volume 20, Number 1, p.95-97 (2005)

URL:

http://www.scopus.com/inward/record.url?eid=2-s2.0-14944348787&partnerID=40&md5=d4121690ea269b81e1676a258a7dde6e

Keywords:

antioxidant, article, cancer radiotherapy, clinical article, controlled study, female, follow up, free radical, glutathione transferase, human, pilot study, prediction, Prognosis, radiation exposure, relapse, serum, tumor regression, uterine cervix carcinoma

Abstract:

We conducted a pilot study wherein serum Glutathione-S-transferase levels were measured before and after radiotherapy in carcinoma cervix patients and correlated with response to treatment during a two-year follow-up period. Out of 17 patients who received radiotherapy, 9 showed a significant decrease (p< 0.005) while 8 showed significant increase (p< 0.004) in post radiotherapy glutathione-S-transferase values as compared to pre treatment values respectively. These patients were followed up for two years and we observed that 71% who had significant increase in post radiotherapy values had relapse of cancer within 2 years where as 66% of those who had significant decrease in post radiotherapy values had no evidence of relapse. This shows that alterations in serum Glutathione-S-transferase levels may help us to predict radiation response.

Notes:

cited By 2

Cite this Research Publication

K. Prabhu, Dr. Damodaran Vasudevan, and Bhat, P. G., “Can serum glutathione-s-transferase levels in carcinoma cervix be a predictor of radiation response?”, Indian Journal of Clinical Biochemistry, vol. 20, pp. 95-97, 2005.

207
PROGRAMS
OFFERED
5
AMRITA
CAMPUSES
15
CONSTITUENT
SCHOOLS
A
GRADE BY
NAAC, MHRD
8th
RANK(INDIA):
NIRF 2018
150+
INTERNATIONAL
PARTNERS